Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
Public ClinicalTrials.gov record NCT01072877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Polidocanol Injectable Foam 0.5%, 1.0%, or 2.0% Compared to Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and may cause discomfort. In this study, patients with varicose veins in the legs will be participating. The purpose of this research study is to evaluate the safety and effectiveness of three different concentrations of an investigational drug, polidocanol injectable foam compared to vehicle (inactive solution) in treating the symptoms and appearance of varicose veins.
Study identification
- NCT ID
- NCT01072877
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 279 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2010 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Nov 2012 (Actual)
- Last update posted
- Apr 21, 2021
2010 – 2012
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | San Diego | California | — | — |
| Not listed | Washington D.C. | District of Columbia | 20007 | — |
| Not listed | Aventura | Florida | 33180 | — |
| Not listed | Bradenton | Florida | 34209 | — |
| Not listed | Oakbrook Terrace | Illinois | 60181 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Kalamazoo | Michigan | 49009 | — |
| Not listed | Hartsdale | New York | 10530 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | North Tonawanda | New York | 14120 | — |
| Not listed | Stony Brook | New York | 10530 | — |
| Not listed | Charlotte | North Carolina | 28207 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Toledo | Ohio | 43606 | — |
| Not listed | Bend | Oregon | 97701 | — |
| Not listed | Clarksville | Tennessee | 37040 | — |
| Not listed | Kirkland | Washington | 98034 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01072877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01072877 live on ClinicalTrials.gov.